Light Mode
$6.52 ↑ +0.00 (+0.00%) Trading Up from the previous close of $6.52, $0.27 below the day’s high of $6.79
-2.73 (-29.51%) / 6M
Momentum, market sentiment, and recent alerts
EMBC reads very good: price sits above both the 20- and 200-day averages, the 12-month move is -51.8%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.